Partial breast irradiation (PBI) concurrent with adjuvant dose-dense doxorubicin and cyclophosphamide (ddAC) chemotherapy in early-stage breast cancer: Preliminary safety results from a feasibility trial

被引：0
|
作者：
Zellars, R.
Frassica, D.
Stearns, V.
Fetting, J.
Armstrong, D.
Myers, L.
Tsangaris, T.
Jacob, L.
Lange, J.
Wolff, A.
机构：
[1] Johns Hopkins Univ, Dept Radiat Oncol, Baltimore, MD USA
[2] Johns Hopkins Univ, Dept Med Oncol, Baltimore, MD USA
[3] Johns Hopkins Univ, Dept Surg, Baltimore, MD USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2006年 / 66卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2006.07.416
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2014
引用
收藏
页码：S217 / S218
页数：2
相关论文
共 50 条
  • [1] Feasibility Trial of Partial Breast Irradiation With Concurrent Dose-Dense Doxorubicin and Cyclophosphamide in Early-Stage Breast Cancer
    Zellars, Richard C.
    Stearns, Vered
    Frassica, Deborah
    Asrari, Fariba
    Tsangaris, Theodore
    Myers, Lee
    DiPasquale, Shirley
    Lange, Julie R.
    Jacobs, Lisa K.
    Emens, Leisha A.
    Armstrong, Deborah K.
    Fetting, John H.
    Garrett-Mayer, Elizabeth
    Davidson, Nancy E.
    Wolff, Antonio C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (17) : 2816 - 2822
  • [2] Phase I/II trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide (ddAC) chemotherapy in early stage breast cancer: Report of skin toxicity and cosmetic outcome
    Zellars, R. C.
    Frassica, D.
    Steams, V.
    Asrari, F.
    Fetting, J. H.
    Armstrong, D. K.
    Myers, L.
    Tsangaris, T.
    Garrett-Mayer, E.
    Wolff, A. C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S26 - S26
  • [3] Phase I/II Trial of Partial Breast Irradiation with Concurrent Dose-dense Doxorubicin and Cyclophosphamide (ddAC) Chemotherapy in Early-stage Breast Cancer: Late Assessment of Toxicity, Cosmetic Outcome, and Disease Recurrence
    Zellars, R.
    DeSouza-Lawrence, L.
    Frassica, D.
    Asrari, F.
    Stearns, V.
    Myers, L.
    Wolff, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S235 - S236
  • [4] Assessment of efficacy and safety of dose-dense doxorubicin and cyclophosphamide (ddAC) in combination with immunotherapy in early-stage triple-negative breast cancer
    White, Olivia
    Dent, Susan
    Westbrook, Kelly
    Lee, Hui-Jie
    Yang, Chengxin
    Moore, Heather N.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2024, 207 (01) : 179 - 185
  • [5] Assessment of efficacy and safety of dose-dense doxorubicin and cyclophosphamide (ddAC) in combination with pembrolizumab in early-stage, triple-negative breast cancer
    White, Olivia
    Dent, Susan Faye
    Westbrook, Kelly E.
    Moore, Heather
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Adjuvant treatment of early-stage breast cancer with eribulin mesylate following dose-dense doxorubicin and cyclophosphamide: preliminary results from a phase 2, single-arm feasibility study
    Traina, T. A.
    Hudis, C.
    Fornier, M.
    Lake, D.
    Lehman, R.
    Berkowitz, A. P.
    Rege, J.
    Liao, J.
    Cox, D.
    Seidman, A. D.
    [J]. CANCER RESEARCH, 2012, 72
  • [7] Weighing a dose-dense option for adjuvant chemotherapy and trastuzumab in early-stage breast cancer
    Mayer, Erica L.
    Burstein, Harold J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (08) : 1198 - 1200
  • [8] Dose-dense adjuvant chemotherapy in early breast cancer patients: Results from a randomized trial
    Venturini, M
    Del Mastro, L
    Aitini, E
    Baldini, E
    Caroti, C
    Contu, A
    Testore, F
    Brema, F
    Pronzato, P
    Cavazzini, G
    Sertoli, MR
    Canavese, G
    Rosso, R
    Bruzzi, P
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (23) : 1724 - 1733
  • [9] Feasibility of dose-dense doxorubicin and cyclophosphamide (ddAC) followed by taxane (T) in Japanese women with early breast cancer: A retrospective study
    Masuda, J.
    Ozaki, Y.
    Nakajima, H.
    Oki, R.
    Uchiyama, M.
    Koganemaru, S.
    Ogura, T.
    Tamura, N.
    Miura, Y.
    Tanabe, Y.
    Miura, D.
    Kawabata, H.
    Takano, T.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 30 - 30
  • [10] Adjuvant dose-dense doxorubicin plus cyclophosphamide followed by dose-dense nab-paclitaxel is safe in women with early-stage breast cancer: a pilot study
    Nicholas Robert
    Lea Krekow
    Chris Stokoe
    Alicia Clawson
    Jose Iglesias
    Joyce O’Shaughnessy
    [J]. Breast Cancer Research and Treatment, 2011, 125 : 115 - 120
12345